Navigation Links
BioConvergence®, Contract Manufacturing Organization for the Life Sciences Industry, Announces New Board of Directors
Date:9/19/2013

Bloomington, IN (PRWEB) September 19, 2013

BioConvergence publicly announced today that they have appointed a new Board of Directors. Kathy Jackson was named as Chair, with Dr. Rafik Bishara, Ken Martlage, and Alisa Wright as board members.

Jackson is a senior executive consultant and a principal with Compete Indiana, LLC. She helps growing organizations to identify and correct strategic gaps within their businesses, especially when pertaining to employee care and customer satisfaction. Jackson guides her clients with the best practices and expertise she utilized over the past 12 years in her senior-level executive positions (including President and CEO of Novia CareClinics, LLC) and in her nearly 20 years spent as an educator.

Bishara is a well-known expert in the pharmaceutical supply chain distribution sector. His specialty of Good Cold Chain and Temperature-Controlled Management has led to numerous industry contributions. He has served on the board or as an advisor to many organizations (including Sensitech, Inc., Cryoport, and the World Health Organization); he is also the current Chair of the Pharmaceutical Cold Chain Interest Group (PCCIG) within the Parenteral Drug Association (PDA). He spent 35 years at Eli Lilly & Co. as Director, Quality Knowledge Management, and Technical Support.

Martlage coaches individuals, teams, and corporations in leadership development. He spent 28 years at Eli Lilly & Co. in various management positions and retired in 2000. The past 13 years have been dedicated to international consulting across multiple industries with Compete Indiana, LLC; Phoenix Images, Inc., and Tercon Consulting. His experience includes coaching senior management, team alignment, and facilitating organizational culture shift. Martlage also spent 12 years as a lecturer at Indiana University-Purdue University Indianapolis (IUPUI).

Alisa Wright, CEO of BioConvergence, said of her fellow board members and of the announcement in general:

“BioConvergence is thrilled that our Board is comprised of people with the passion and know-how needed to take our firm to the next level. In the last year, each of the board members has been collaborating with internal teams to improve operations. Because of what we have accomplished, I am anticipating more great things for the Company and its clients in the coming year.”

Wright notes that the backgrounds and experience levels of the Board’s members will support and compliment the Company’s objectives.

Wright began her career in the pharmaceutical industry with firms such as Eli Lilly & Co., Cook Pharmaceutical Solutions, and Baxter Pharmaceutical Solutions. During her 25 years of experience, she identified many industry gaps; in response, she founded BioConvergence to help companies consolidate their supplier base, mitigate risk, and speed products to market, all in an effort to provide patients with better healthcare treatments. BioConvergence is in its seventh year of service.    

Erick Ponader, Partner at Taft Stettinius & Hollister LLP, continues to serve BioConvergence as General Counsel.

For more information, please visit http://bioc.us/about-us/board-of-directors/

About BioConvergence

BioConvergence is a contract manufacturing organization for the life sciences industry, offering outsourcing partnerships for formulation development, testing, production, and supply chain services. Headquartered in Bloomington, Indiana, they have over 50 employees with five centuries’ worth of combined experience in the pharmaceutical industry. Their unique E-Transparency® System provides transparency and flexibility to their clients, while offering superior, quality-driven outsourcing services. For more information, visit http://www.bioc.us.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11142351.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. HerbalGram Article Details Procedures for Choosing a Contract Analytical Lab for Dietary Ingredients
2. Bio/Pharmaceutical Contract Manufacturing - Industry Analysis of Dose Manufacturing by the Numbers: Composition, Size, Market Shares, Profitability and Outlook
3. Pharma Contract Manufacturing, Research & Packaging Market a New Report Available at ReportsnReports.com
4. Indiana University Contracts with Virtify for Clinical Trial Disclosure Solutions
5. Fortune 500 Company Contracts with Wireless Analytics to Extend Wireless Expense Management & Mobility Management Services Internationally
6. Boehringer Laboratories LLC Awarded HPG Contract for Clinical Suction Regulators
7. PharmSource CMO-CDMO Database Expands Coverage to Include Approved Pharmaceutical Products: Intelligence Resource for Analyzing Bio/Pharmaceutical Contract Manufacturing
8. Clinical Development, Contracts and Outsourcing in MENA & APAC, New Webinar Hosted by Xtalks
9. ChanTest Develops New Cardiotoxicity and Contractility Assay with Human Stem Cell Cardiomyocytes
10. Non-Intrusive Rust Remover Gives Out New Set of Samples to Rust Contractors, My Cleaning Products Says the Spray Cuts $1,000s of Rust Removal Expense
11. BioConvergence® Celebrates Seventh Anniversary as a Life Sciences Contract Service Provider
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016  Global demand for enzymes is ... 2020 to $7.2 billion.  This market includes enzymes ... products, biofuel production, animal feed, and other markets) ... biocatalysts). Food and beverages will remain the largest ... consumption of products containing enzymes in developing regions.  ...
(Date:6/27/2016)... ... 27, 2016 , ... Newly created 4Sight Medical Solutions ... the healthcare market. The company's primary focus is on new product introductions, to ... that are necessary to help companies efficiently bring their products to market. , ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
Breaking Biology Technology:
(Date:6/21/2016)... VANCOUVER, British Columbia , June 21, 2016 ... been appointed to the new role of principal ... has been named the director of customer development. ... , NuData,s chief technical officer. The moves reflect ... development teams in response to high customer demand ...
(Date:6/16/2016)... 2016 The global ... reach USD 1.83 billion by 2024, according to ... Technological proliferation and increasing demand in commercial buildings, ... drive the market growth.      (Logo: ... development of advanced multimodal techniques for biometric authentication ...
(Date:6/9/2016)... control systems is proud to announce the introduction of fingerprint attendance control software, allowing ... are actually signing in, and to even control the opening of doors. ... ... ... Photo - http://photos.prnewswire.com/prnh/20160609/377487 ...
Breaking Biology News(10 mins):